Philippe Jaillard, MPH, MSc

 

Leader – Health Systems and Supply Chain strengthening

Director of Business Development and Partnerships

Chairman

 

Philippe is a senior specialist in health systems and supply chain. He has an extensive background in operational and field research, human resource development and capacity building. He recently designed and conducted field studies to support the development of new vaccine delivery technologies in poor settings, some of them leading to WHO recommendations for pre-qualification. He established and managed the LOGIVAC Center, a health supply chain training and research center in Benin serving Francophone African countries, and supported the development of a second center in Rwanda to serve East African countries.

In his previous role as Leader of the Health Technologies and logistics program at the ‘Agence de Médecine preventive’ (AMP), Philippe led AMP support to developing countries in areas including vaccine delivery, cold chain equipment management, injection safety and waste management, human resources, and logistics and programmatic issues related to the introduction of new vaccines. He was responsible for coordinating and monitoring the portfolio of projects and studies comprising operational research, technical assistance, and human resource development and capacity building in low and middle income countries. From 2006 to 2014 he was appointed as a country representative for AMP in Burkina Faso and Benin.

Philippe was co-awarded the 2014 Gates Vaccine Innovation Award in recognition of his engagement in EPIVAC, an on-the-job training program for district medical officers to improve immunization program performance in 11 Francophone African countries. Since 2016, Philippe has been serving as member of the WHO Delivery Technology Working Group. He is serving as member of the Gavi Independent review committee since 2014 and the High Level Review Panel since 2018.

Philippe holds a Master degree in project development and a University Degree in Public Health.

As co-founder and chairman of EpiLinks, Philippe is responsible for the business development, including definition of the strategy, development of partnerships and acquisition of projects.

Publications

Professional changes induced by a redesigned immunization supply chain in the Comé Health Zone, Benin. 2017

Guillermet E, Alfa DA, Gbodja R, Jaillard P.

Professional changes induced by a redesigned immunization supply chain in the Comé Health Zone, Benin. Vaccine. 2017 Apr 19;35(17):2189-2194. doi: 10.1016/j.vaccine.2016.12.074. PubMed PMID: 28364929.

Costing analysis and anthropological assessment of the vaccine supply chain system redesign in the Comé District , Benin. 2017

Huang XX, Guillermet E, Le Gargasson JB, Alfa DA, Gbodja R, Sossou AJ, Jaillard P.

Costing analysis and anthropological assessment of the vaccine supply chain system redesign in the Comé District (Benin). Vaccine. 2017 Apr 19;35(17):2183-2188. doi: 10.1016/j.vaccine.2016.12.075. PubMed PMID: 28364928.

System redesign of the immunization supply chain: Experiences from Benin and Mozambique. 2017

Prosser W, Jaillard P, Assy E, Brown ST, Matsinhe G, Dekoun M, Lee BY.

System redesign of the immunization supply chain: Experiences from Benin and Mozambique. Vaccine. 2017 Apr 19;35(17):2162-2166. doi: 10.1016/j.vaccine.2016.09.073. PubMed PMID: 28364925.

Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review. 2017

Eriksson P, Gessner BD, Jaillard P, Morgan C, Le Gargasson JB.

Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review. Vaccine. 2017 Apr 19;35(17):2155-2161. doi: 10.1016/j.vaccine.2016.11.102. Review. PubMed PMID: 28364924.

Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal. 2015

Guillermet E, Dicko HM, Mai le TP, N’Diaye M, Hane F, Ba SO, Gomis K, Tho NT, Lien NT, Than PD, Dinh TV, Jaillard P, Gessner BD, Colombini A.

Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal. PLoS One. 2015 Jul 17;10(7):e0132292. doi: 10.1371/journal.pone.0132292. eCollection 2015. PubMed PMID: 26186456; PubMed Central PMCID: PMC4506041.

The Benin experience: How computational modeling can assist major vaccine policy changes in low and middle income countries. 2015

Lee BY, Schreiber B, Wateska AR, Connor DL, Dicko HM, Jaillard P, Mvundura M, Levin C, Avella M, Haidari LA, Brown ST.

The Benin experience: How computational modeling can assist major vaccine policy changes in low and middle income countries. Vaccine. 2015 Jun 9;33(25):2858-61. doi:10.1016/j.vaccine.2015.04.022. Epub 2015 Apr 18. PubMed PMID: 25900134; PubMedCentral PMCID: PMC4623312.

A field based evaluation of adverse events following MenAfriVac® vaccine delivered in a controlled temperature chain (CTC) approach in Benin. 2014

Steffen C, Tokplonou E, Jaillard P, Dia R, Alladji MN, Gessner B.

A field based evaluation of adverse events following MenAfriVac® vaccine delivered in a controlled temperature chain (CTC) approach in Benin. Pan Afr Med J. 2014 Aug 28;18:344. doi: 10.11604/pamj.2014.18.344.3975. eCollection 2014. PubMed PMID: 25574320; PubMed Central PMCID: PMC4282804.

One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery. 2015

Haidari LA, Wahl B, Brown ST, Privor-Dumm L, Wallman-Stokes C, Gorham K, Connor DL, Wateska AR, Schreiber B, Dicko H, Jaillard P, Avella M, Lee BY.

One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery. Vaccine. 2015 Jun 22;33(28):3242-7. doi:10.1016/j.vaccine.2015.04.018. Epub 2015 Apr 15. PubMed PMID: 25889160; PubMedCentral PMCID: PMC4623324.

Costs for households and community perception of meningitis epidemics in burkina faso. 2009

Colombini A, Bationo F, Zongo S, Ouattara F, Badolo O, Jaillard P, Seini E, Gessner BD, Da Silva A.

Costs for households and community perception of meningitis epidemics in burkina faso. Clin Infect Dis. 2009 Nov 15;49(10):1520-5. doi: 10.1086/644623. Review. PubMed PMID: 19842972.

Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. 2011

Delrieu I, Yaro S, Tamekloé TA, Njanpop-Lafourcade BM, Tall H, Jaillard P, Ouedraogo MS, Badziklou K, Sanou O, Drabo A, Gessner BD, Kambou JL, Mueller JE.

Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS One. 2011;6(5):e19513. doi: 10.1371/journal.pone.0019513. Epub2011 May 20. PubMed PMID: 21625480; PubMed Central PMCID: PMC3098835.

Costs and impact of meningitis epidemics for the public health system in Burkina Faso. 2011

Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A.

Costs and impact of meningitis epidemics for the public health system in Burkina Faso. Vaccine. 2011 Jul 26;29(33):5474-80. doi: 10.1016/j.vaccine.2011.05.058. Epub 2011 Jun 12. PubMed PMID: 21641952.

The benefits of redesigning Benin's vaccine supply chain. 2014

Brown ST, Schreiber B, Cakouros BE, Wateska AR, Dicko HM, Connor DL, Jaillard P, Mvundura M, Norman BA, Levin C, Rajgopal J, Avella M, Lebrun C, Claypool E, Paul P, Lee BY.

The benefits of redesigning Benin’s vaccine supply chain. Vaccine. 2014 Jul 7;32(32):4097-103. doi: 10.1016/j.vaccine.2014.04.090. Epub 2014 May 9. PubMed PMID: 24814550.